| Endometriosis |
1 |
1 |
| Surgery |
0 |
0.92 |
| Laparoscopic Surgery |
0 |
0.68 |
| Gonadotropin-Releasing Hormone (GnRH) Antagonist |
0 |
0.33 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.32 |
| Pain Management |
0 |
0.95 |
| Dysmenorrhea |
0 |
0.09 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.09 |
| Biomarker |
0 |
0.05 |
| Connecticut |
0 |
0.05 |
| Drug Costs |
0 |
0.05 |
| Oregon |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Postoperative |
0 |
0.99 |
| Quality of Life |
0 |
0.9 |
| Refractory |
0 |
0.05 |